trastuzumab deruxtecan,ruxolitinib
daiichi sankyo,novartis,astrazeneca,incyte
['solid tumor', 'trastuzumab deruxtecan', 'rux,(-crux),(-trux)']
our dr. funda meric-bernstam presented a study at #asco23 showing promising results for use of trastuzumab deruxtecan for several her2-expressing solid tumors, including those that are hard to treat. learn about it here: #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789